![CDC recommends new COVID booster for all Americans over 6 months amid rising cases, hospitalizations - ABC News CDC recommends new COVID booster for all Americans over 6 months amid rising cases, hospitalizations - ABC News](https://i.abcnewsfe.com/a/8751bb25-b566-4440-9e9c-72099e9696bf/covid-2-rt-bb-230906_1694012668027_hpEmbed_3x2.jpg)
CDC recommends new COVID booster for all Americans over 6 months amid rising cases, hospitalizations - ABC News
![Ministero della Salute, avvio della somministrazione di dosi “booster” nell'ambito della campagna di vaccinazione anti SARS-CoV-2/COVID-19 - Federazione Nazionale degli Ordini dei Biologi Ministero della Salute, avvio della somministrazione di dosi “booster” nell'ambito della campagna di vaccinazione anti SARS-CoV-2/COVID-19 - Federazione Nazionale degli Ordini dei Biologi](https://www.fnob.it/wp-content/uploads/2020/12/vaccino_covid-1.jpg)
Ministero della Salute, avvio della somministrazione di dosi “booster” nell'ambito della campagna di vaccinazione anti SARS-CoV-2/COVID-19 - Federazione Nazionale degli Ordini dei Biologi
![Updated Covid-19 boosters offer protection, but new studies suggest they don't offer an edge against Omicron | CNN Updated Covid-19 boosters offer protection, but new studies suggest they don't offer an edge against Omicron | CNN](https://media.cnn.com/api/v1/images/stellar/prod/221024193034-covid-19-booster-090922.jpg?c=original)
Updated Covid-19 boosters offer protection, but new studies suggest they don't offer an edge against Omicron | CNN
![Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7148e1-BivalentBooster_IMAGE_22NOV2022_1200x675.jpg?_=65732)
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
![First SARS-CoV-2 vaccine booster and influenza vaccination: risk assessment of COVID-19 hospitalisation and death | Epidemiologia&Prevenzione First SARS-CoV-2 vaccine booster and influenza vaccination: risk assessment of COVID-19 hospitalisation and death | Epidemiologia&Prevenzione](https://epiprev.it/documenti/get_image.php?img=files/2022/ep5-6_2022/advance/art-tunesi2_img.jpg)
First SARS-CoV-2 vaccine booster and influenza vaccination: risk assessment of COVID-19 hospitalisation and death | Epidemiologia&Prevenzione
Da mercoledì 2 marzo al via la somministrazione della quarta dose “booster” alle persone con marcata compromissione della risposta immunitaria a partire dai dializzati. — Azienda USL di Bologna
![Azienda sanitaria universitaria Friuli Centrale (ASU FC) - Campagna di vaccinazione anti SARS-CoV-2/COVID-19 Azienda sanitaria universitaria Friuli Centrale (ASU FC) - Campagna di vaccinazione anti SARS-CoV-2/COVID-19](https://asufc.sanita.fvg.it/export/sites/asufc/it/immagini/news/vaccine-covid_orario.jpg_1096166689.jpg)